 |
 |
 |
 |
|
|
|
|
 |
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|||||||||||||||||
|
|
Dispatch Dengue Epidemic in Southern Vietnam, 1998Do Quang Ha, Nguyen Thi Kim Tien, Vu Thi Que Huong, Huynh Thi Kim Loan, Cao Minh Thang
Since 1963, the incidence of dengue hemorrhagic fever (DHF), a leading cause of hospitalization and death in children, has steadily increased in Vietnam. In 1998, a widespread DHF epidemic affected 19 provinces in southern Vietnam (Figure 1); 119,429 cases of DHF and 342 deaths were reported (Figure 2); and the rates per 100,000 population were 438.98 and 1.26, respectively, for a case-fatality rate of 0.29%, an increase of 152.4% and 151.8% over those of a 1997 epidemic (288.02 and 0.83)(1). The epidemic curve was similar to those of previous years: cases increased substantially from June to November (1-4). Peak transmission occurred from July to September, closely associated with the rainy season, a breeding period for the mosquito vector. DHF cases were reported in the first quarter in Ben Tre (1,387.2/2.4/100,000), Binh Phuoc (635.1/0), and Kien Giang Provinces (568.4/2.9). We describe epidemiologic, virologic, and serologic studies carried out during the epidemic. The StudyReports of DHF cases and deaths were gathered by hospitals and Departments of Hygiene and Preventive Medicine at the district level, then sent to the Provincial Centers of Preventive Medicine. These data were reported weekly to the Pasteur Institute in Ho Chi Minh City. Seventeen of the 19 provinces submitted blood samples to the Institute for virus isolation. One hundred forty-three dengue viruses were isolated from 1,236 blood samples, for a positivity rate of 11.6% (Table 1). Although DEN-1 and DEN-2 had been the most common serotypes (1-4), DEN-3 was isolated in 15 provinces. The blood samples were obtained on days 1 to 4 after the onset of illness and were stored at -20°C or -70°C before being injected into C6/36 (Aedes albopictus) cell cultures seeded at 3 x 105 cells per mL in 1-mL glass tubes. Undiluted blood was injected into duplicate tubes (0.05 mL per tube) and incubated at 28°C for 7 days. Infected cell cultures were harvested and assayed for dengue virus by the direct and indirect fluorescent antibody techniques, with the monoclonal antibody SLE 6B6C-1/FITC conjugate and four serotype-specific monoclonal antibodies: DEN-1 (Hawaii 15F3-1-15 and D2-1F1-3), DEN-2 (NGC 3H5-1-21), DEN-3 (H87 5D4-11-24), DEN-4 (H241 1H10-6-7), and Japanese encephalitis (Nakayama 14H5) (5). To detect dengue-specific IgM antibody, samples were tested by IgM-capture enzyme-linked immunosorbent assay (Mac-ELISA) by using the monoclonal antibody SLE 6B6C-1/HRP conjugate (6). Sixteen of 19 provinces in southern Vietnam submitted patient sera for dengue serodiagnosis. Seropositive results were seen in all provinces throughout the year, and the confirmation rates increased during the DHF season (Table 2). Despite the high sensitivity and specificity of Mac-ELISA for dengue diagnosis, the seropositivity rates in eight provinces were low (< 50%). Clinical diagnoses of DHF during the epidemic in these provinces may have been overestimated, especially in cases of suspected DHF or fever of unknown origin. As a result, hospitals in these provinces were overwhelmed by patients, to the extent that the quality of treatment has been affected.
ConclusionsDuring 1990-1998, dengue viruses were most often recovered in children 5 to 14 years of age (3). In the 1998 outbreak, more dengue viruses were isolated from adults (18.2%) than in the previous 4 years. Adults are not likely to have been exposed to the emerging DEN-3 virus. From 1987 to 1998, the dengue virus serotypes in circulation changed (3). DEN-2 was responsible for the 1987 epidemic. From 1990 to 1995, DEN-1 predominated, but had decreased to 11.9% by 1998. DEN-2 accounted for 42.2% of the serotypes identified in 1997, but had decreased to 14.7% by 1998. The circulation of DEN-3 was the lowest during 1987-1994; increased to 29.5% by 1996, 42.2% by 1997, and 70.6% in 1998; and was the predominant serotype of the 1998 epidemic.DEN-3 virus was first detected in 1987 only in Ho Chi Minh City, but by 1991 it was also identified in Tien Giang Province (7). In 1994 it appeared in Tien Giang and Soc Trang, in 1997 in four additional provinces, and by 1998 in 15 provinces. After a 5-year absence, DEN-4 virus was also detected in Dong Thap and Tra Vinh Provinces in the Mekong Delta. During a 1998 DHF epidemic affecting 19 provinces in southern Vietnam, 119,429 cases and 342 deaths were reported, for an increase of 152.4% and 151.8%, respectively, over 1997. It was the largest DHF epidemic in Vietnam since 1963. DEN-3, which began to emerge in southern Vietnam in 1994, was the serotype associated with the 1998 epidemic. The simultaneous emergence of DEN-4 should alert public health officials to the potential for outbreaks associated with that serotype. Virologic and serologic surveillance indicate that dengue is endemic in southern Vietnam and that the Dengue Control Program should be implemented in the interepidemic phase--in the first quarter of every year. AcknowledgmentsWe thank D.J. Gubler for providing the monoclonal antibodies used in this study. Address for correspondence: Do Quang Ha, Pasteur Institute, 167 Pasteur Street, District 3 Ho Chi Minh City, Vietnam; fax: 84-8-8231419; e-mail: pvtu@netnam2.org.vn References
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us CDC Home | Search | Health Topics A-Z This page last reviewed July 10, 2000 Emerging Infectious Diseases Journal |
